Yeah, I see it posted and I raise you mine. Surely, you've made a boat load of money flipping Algernon and previous Breathtec :-D My guess is you picked up some scraps left behind by King Cobra. That's the only clown who made a killing here. Yeah. I'll admit it. I had no idea how incompetent management would be at it's repurposed drugs strategy. Launching Phase II studies for sh!ts and giggles wasn't something I expected. Now it's Phase I studies that dominate 2022. Yeah, their biotech acumen was definitely unsuspecting. Especially when you go back and look at all the video nonsense they told shareholders ("65% chance of success!") leading up to data for covid and subsequently IPF/CC. Right up until we were told neither study was powered to get to statistical significance. Back to Back flip flops. Yeah, one should always factor in flipping pennies based on those type of insane management skills. Surely, someone has to sing the praises of failures by management. It simply won't be me. Meanwhile, tell beer buddy to put a call in to it's Ambassador that knows POTUS to get the frigging uplist done ASAP.
M$
News 
Market Data 
Discover 
